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dementia in general to any substantial extent. If
anything, persistent smoking may increase rather than
decrease the onset rate of dementia, but any net effect
on severe dementia cannot be large in either direction.
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Abstract
Objective To investigate international variations in
smoking associated with educational level.
Design International comparison of national health,
or similar, surveys.
Subjects Men and women aged 20 to 44 years and 45
to 74 years.
Setting 12 European countries, around 1990.
Main outcome measures Relative differences (odds
ratios) and absolute differences in the prevalence of
ever smoking and current smoking for men and
women in each age group by educational level.
Results In the 45 to 74 year age group, higher rates
of current and ever smoking among lower educated
subjects were found in some countries only. Among
women this was found in Great Britain, Norway, and
Sweden, whereas an opposite pattern, with higher
educated women smoking more, was found in
southern Europe. Among men a similar north›south
pattern was found but it was less noticeable than
among women. In the 20 to 44 year age group,
educational differences in smoking were generally
greater than in the older age group, and smoking
rates were higher among lower educated people in
most countries. Among younger women, a similar
north›south pattern was found as among older
women. Among younger men, large educational
differences in smoking were found for northern
European as well as for southern European countries,
except for Portugal.
Conclusions These international variations in social
gradients in smoking, which are likely to be related to
differences between countries in their stage of the
smoking epidemic, may have contributed to the
socioeconomic differences in mortality from
ischaemic heart disease being greater in northern
European countries. The observed age patterns
suggest that socioeconomic differences in diseases
related to smoking will increase in the coming
decades in many European countries.
Introduction
Socioeconomic inequalities in health have been found
in all countries where data are available, and there is an
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increasing interest in making international compari›
sons of their pattern and size.1–4 The results of these
comparisons lead on to new questions about socioeco›
nomic gradients in specific risk factors for disease, such
as smoking.
Until now only a few studies have compared the
magnitude of socioeconomic differences in smoking
between countries.5–7 The most comprehensive com›
parison described differences in prevalence of smoking
by educational level in the United Kingdom, Finland,
Sweden, Norway, and France around 1987.6 In all these
countries, lower educated people smoked more than
higher educated people. The largest differences were
observed in the United Kingdom and Norway. The
international comparability of the data in this study
was, however, not optimal.5 6
We compared socioeconomic differences in smok›
ing in 12 European countries, including Denmark,
Germany, the Netherlands, Switzerland, Portugal,
Spain, and Italy. We assessed data from national health,
or similar, surveys for 1986›94. To optimise the
comparability of the data, we reanalysed original data
sources and we reclassified the data according to
standard specifications.
Subjects and methods
Surveys and respondents
Table 1 shows the data sources and some characteris›
tics of the surveys. Mostly the data came from national
health interview surveys, but in some countries data
came from multipurpose or level of living surveys.
Sampling procedures, non›response rates, and inter›
view methods differed between countries. We restricted
our analysis to respondents aged 20 to 74 years, rang›
ing from 4000 respondents in Denmark to 37 000 in
Italy. We analysed men and women and two age groups
(20 to 44 and 45 to 74 years) separately.
We analysed the percentage of both people who
ever smoked (current and former smokers) and people
who were current smokers. As the percentage of
people who were current cigarette smokers gave simi›
lar international patterns of inequalities in smoking as
the percentage of current smokers, we decided to
report on current smokers only.
Educational level
We chose educational level as an indicator of
socioeconomic status. We did consider measuring
educational level by years of education, but as this did
not include the type and level of education and was not
available for all the countries, we chose the highest level
of education completed by the individual. In each coun›
try we regrouped educational levels according to a
standard classification: 1, no education completed; 2, first
level (primary school); 3, lower secondary level; 4, upper
secondary level; and 5, tertiary level, which included uni›
versity and other forms of education after the secondary
level.8 We quantified educational differences in smoking
in several ways, but as these provided similar results we
decided to present the comparison of a “low educated”
(levels 1›3) group with a “high educated” (levels 4 and 5)
group, as these included all educational levels.
Statistical analysis
We used logistic regression analyses for each country
to determine the differences in the percentage of
current smokers and ever smokers between the two
educational groups by sex and age group, with the high
educational group as the reference group. To correct
for age a nominal variable representing five year age
groups was included in the regression model. Odds
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Table 1 Characteristics of surveys
Country Year Name Sampling source
Excluded
subpopulations
Nn›
response
rate (%)
No of
respondents
aged 20›74
years*
Proportion
(%) of 20›74
years in
national
population
Interview
method for
smoking
behaviour
Denmark 1986›7 Danish health and morbidity survey Population
register
Foreigners 20 4 000 0.11 Face to face
Finland 1990›1 Health behaviour among the Finnish
adult population
Population
register
Institutionalised
people
26 6 700 0.19 Self
administered
questionnaire
France 1991 EnquŒte sur la santØ et les soins
medicaux
Population
register
Institutionalised
people
17 13 400 0.04 Face to face
West
Germany
1988›91 Life and health in Germany Population
register
Foreigners 30 10 600 0.02 Self
administered
questionnaire
Great Britain 1990›1 General household survey Postal or address
files
Institutionalised
people
15 15 000 0.04 Face to face
Italy 1990›1 Multiple household survey Population
register
Institutionalised
people
11 37 000 0.09 Face to face
Netherlands 1991›2 Netherlands health interview survey Postal or address
files
Institutionalised
people
43 10 200 0.10 Self
administered
questionnaire
Norway 1992›4 Multi purpose survey Population
register
Institutionalised
people
25 5 000 0.18 Face to face
Portugal 1987 National health survey Population
register
Institutionalised
people
26 23 700 0.36 Face to face
Spain 1987 National health survey Postal or address
files
Institutionalised
people
10 24 900 0.10 Face to face
Sweden 1991 Swedish level of living survey Population
register
› 21 4 900 0.08 Face to face
Switzerland 1992›3 Swiss health survey Telephone
directory
Institutionalised
people
29 13 300 0.28 Telephone
*Age limits for West Germany are 24 and 69 years; upper age limit for Finland is 64 years; lower age limit for Portugal is 25 years.
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ratios and 95% confidence intervals were calculated
from the regression coefficients and their standard
errors. To test whether odds ratios varied significantly
between countries we performed additional analyses
for all countries combined, including terms represent›
ing the interaction between education and country.
The proportion of men and women in the low edu›
cated group was higher in France, Italy, Spain, and Por›
tugal than in the other countries. To avoid comparisons
of the odds ratios between the countries being affected
by variations in the size of the educational groups, we
also calculated the relative index of inequality.9–11 In this
index all educational levels are taken into account
separately, with an adjustment for the size of the
educational groups. Generally the estimates of relative
index of inequality showed the same international pat›
terns as the odds ratios on the basis of the two
educational groups; the correlation between the two
indices was generally high (r > 0.9, P < 0.01). Because of
the high correspondence between the two inequality
indices, we present only the simpler odds ratio.
Absolute rate differences were added to the odds
ratios because they take into account differences
between countries in the overall prevalence of smoking.
Absolute differences were calculated by subtracting the
prevalence rate of smoking in the higher educated
group from that of the lower one. To correct for
differences in age between the educational groups we
used indirect standardisation for each country and sex.
Results
Relative differences among men
Table 2 shows the average prevalence rates of smoking
and the relative differences in smoking between
educational groups among men. The proportion of
current smokers ranged from 32%›64% among the
younger men, and from 28%›55% among the older
men. The proportion of current smokers was generally
lower than that of ever smokers, suggesting a sizeable
group of ex›smokers.
Most odds ratios for current smoking were greater
than 1.00, indicating a higher prevalence of smoking in
the lower educated group. The odds ratios were usually
higher among the younger than older men. The high›
est odds ratios among younger men were observed in
Norway, Sweden, France, and Great Britain whereas
among older men the highest odds ratios were
observed in Great Britain and Norway. The only odds
ratios that were clearly less than 1.00 were observed in
Table 2 Prevalence of smoking among men from 12 European countries and differences between low and high educational levels
(high educated group is reference category)
Country
Age group (20›44 years) Age group (45›74 years)
Ever smoking Current smoking Ever smoking Current smoking
% Odds ratio (95% CI) % Odds ratio (95% CI) % Odds ratio (95% CI) % Odds ratio (95% CI)
Denmark 64.7 0.94 (0.64 to 1.38) 50.0 1.34 (0.94 to 1.91) 85.1 1.11 (0.74 to 1.67) 55.2 1.06 (0.79 to 1.43)
Finland 70.2 1.68 (1.27 to 2.22) 47.1 1.57 (1.24 to 1.98) 73.1 1.02 (0.78 to 1.34) 36.1 1.00 (0.78 to 1.29)
France 66.6 2.27 (1.96 to 2.63) 48.0 2.32 (2.01 to 2.68) 71.6 1.02 (0.84 to 1.25) 31.2 1.19 (0.97 to 1.45)
West Germany 71.7 1.51 (1.24 to 1.82) 48.8 1.56 (1.32 to 1.85) 74.9 1.31 (1.08 to 1.58) 34.8 1.50 (1.27 to 1.78)
Great Britain 58.9 2.01 (1.71 to 2.37) 42.2 2.26 (1.94 to 2.64) 78.4 1.58 (1.31 to 1.89) 36.5 1.74 (1.47 to 2.05)
Italy 57.3 1.69 (1.56 to 1.83) 44.3 1.69 (1.56 to 1.82) 71.1 1.11 (0.98 to 1.26) 37.8 1.09 (0.97 to 1.23)
Netherlands 69.1 1.66 (1.39 to 1.99) 46.3 1.81 (1.55 to 2.12) 88.1 1.25 (0.95 to 1.64) 42.7 1.21 (1.02 to 1.45)
Norway 59.7 2.71 (2.12 to 3.46) 40.0 2.87 (2.28 to 3.60) 75.5 1.39 (1.05 to 1.84) 34.7 1.73 (1.33 to 2.24)
Portugal 62.0 0.70 (0.61 to 0.81) 47.2 0.80 (0.70 to 0.91) 54.2 0.51 (0.43 to 0.61) 27.7 0.65 (0.54 to 0.77)
Spain 75.4 1.43 (1.26 to 1.62) 64.2 1.54 (1.37 to 1.72) 75.9 0.94 (0.77 to 1.14) 48.9 0.97 (0.82 to 1.15)
Sweden 51.4 2.52 (1.94 to 3.27) 31.9 2.59 (2.00 to 3.34) 68.7 1.08 (0.84 to 1.40) 30.3 1.50 (1.15 to 1.96)
Switzerland 57.7 1.35 (1.09 to 1.66) 42.0 1.23 (1.01 to 1.51) 72.0 1.13 (0.91 to 1.42) 33.7 1.31 (1.06 to 1.61)
Total 63.6 1.54 (1.47 to 1.65) 47.5 1.65 (1.58 to 1.72) 71.2 1.05 (0.99 to 1.11) 36.9 1.18 (1.12 to 1.25)
Education v country P<0.001 P<0.001 P<0.001 P<0.00
Table 3 Prevalence of smoking among women from 12 European countries and differences between low and high educational levels
(high educated group is reference category)
Country
Age group (20›44 years) Age group (45›74 years)
Ever smoking Current smoking Ever smoking Current smoking
% Odds ratio (95% CI) % Odds ratio (95% CI) % Odds ratio (95% CI) % Odds ratio (95% CI)
Denmark 61.2 1.27 (0.85 to 1.90) 49.1 1.28 (0.87 to 1.89) 65.9 1.14 (0.84 to 1.48) 45.3 1.20 (0.89 to 1.60)
Finland 59.0 1.64 (1.29 to 2.09) 33.5 1.93 (1.53 to 2.44) 35.8 0.80 (0.63 to 1.02) 18.7 1.14 (0.85 to 1.52)
France 46.6 1.10 (0.96 to 1.26) 31.2 1.36 (1.18 to 1.58) 18.3 0.42 (0.34 to 0.52) 9.9 0.61 (0.46 to 0.81)
Italy 33.5 0.99 (0.91 to 1.08) 25.5 1.10 (1.01 to 1.21) 19.9 0.37 (0.32 to 0.43) 13.3 0.46 (0.39 to 0.54)
Netherlands 67.2 1.58 (1.33 to 1.87) 41.1 1.67 (1.43 to 1.94) 51.4 0.75 (0.62 to 0.90) 24.2 1.37 (1.10 to 1.70)
Norway 58.2 3.21 (2.53 to 4.11) 37.5 2.64 (2.09 to 3.34) 51.4 1.84 (1.37 to 2.48) 28.9 2.73 (1.90 to 3.93)
West Germany 60.4 1.25 (1.04 to 1.51) 39.0 1.52 (1.26 to 1.82) 34.1 0.63 (0.53 to 0.73) 18.5 0.98 (0.81 to 1.20)
Great Britain 49.4 2.04 (1.78 to 2.34) 34.6 2.50 (2.17 to 2.89) 51.4 1.58 (1.34 to 1.86) 27.6 2.07 (1.70 to 2.51)
Portugal 12.5 0.12 (0.10 to 0.15) 9.1 0.13 (0.11 to 0.17) 2.2 0.06 (0.04 to 0.08) 1.4 0.05 (0.04 to 0.09)
Spain 48.1 0.53 (0.47 to 0.60) 39.7 0.57 (0.50 to 0.64) 6.5 0.22 (0.16 to 0.29) 3.9 0.29 (0.20 to 0.42)
Sweden 55.3 2.37 (1.82 to 3.09) 33.2 2.34 (1.81 to 3.03) 45.9 1.22 (0.94 to 1.56) 26.7 1.41 (1.06 to 1.87)
Switzerland 50.8 1.24 (1.04 to 1.48) 32.5 1.50 (1.26 to 1.80) 35.5 0.89 (0.76 to 1.04) 18.7 1.16 (0.96 to 1.40)
Total 46.2 1.02 (0.98 to 1.07) 31.0 1.18 (1.13 to 1.24) 23.9 0.69 (0.65 to 0.73) 13.5 0.99 (0.92 to 1.06)
Education v country P<0.001 P<0.001 P<0.001 P<0.001
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Portugal where smoking was more prevalent in the
higher educated group among both groups of men.
The odds ratios for ever smoking tended to be
slightly lower than those for current smoking, implying
that educational differences in smoking are not only
the result of differences in uptake of smoking but also
of a higher rate of quitting among the higher educated
groups.
Relative differences among women
The percentage of current smokers among women was
generally lower than that among men, particularly in
the older age group (table 3). In Spain and Portugal
less than 5% of older women were current smokers.
In most countries the social gradient of current
smoking was as clear among younger women as it was
among younger men. The highest odds ratios were
found in Norway, Sweden, and Great Britain, and the
only odds ratios less than 1.00 were found in Spain and
Portugal. Among older women the highest odds ratios
were again found in Norway and Great Britain, but
here there are more countries than for younger
women (and for older men) where smoking is more
prevalent in the higher educated groups and therefore
the odds ratios are less than 1.00: this is the case in
France, Italy, Spain, and Portugal.
Absolute differences
The figure shows the absolute difference in current
smoking between educational levels, by sex and age
group. These differences showed the same international
patterns as the odds ratios. A high correspondence
between absolute and relative measures was also
observed for ever smoking (results not shown).
Discussion
Evaluation of data problems
A potential problem relates to the accuracy of survey
estimates of prevalence rates of smoking. Non›
response and the use of self reports to measure smok›
ing probably led to an underestimation of national
prevalence rates of smoking.12 13 The international pat›
terns reported here, however, will only be biased when
this underestimation is associated with education and
when countries vary in the strength of this association.
A Swedish study investigated the effect of non›
response (37%) in a health survey on socioeconomic
differences in smoking.14 Despite large differences in
smoking rates between respondents and non›
respondents, socioeconomic differences in smoking
were not substantially or consistently underestimated
or overestimated. Non›response is therefore unlikely to
have had a major effect on our results. A few other
studies have investigated whether underreporting of
smoking is related to socioeconomic status. No associ›
ation was found between underreporting and socio›
economic status among middle aged Danish men.15 A
higher rate of underreporting of smoking, however,
was found among lower educated men and women in
the United States,16 whereas a US study among
immigrants from south east Asia found an association
for women but not for men.17 These inconsistent
results seem to imply that the association between edu›
cation and underreporting varies between countries,
men and women, and perhaps over time, possibly due
to variations in social norms concerning smoking.
Therefore we cannot exclude the possibility that the
international position of some countries is biased as a
result of the use of self reports to measure smoking.
The available evidence, however, does not suggest that
the pronounced international patterns we observed
can be explained completely in this way.
Other potential problems relate to international dif›
ferences in sampling, interview method, and questions
used to measure smoking behaviour. However, the effect
of these differences on the international patterns
reported is probably marginal as the differences in smok›
ing corresponded well with the estimates we obtained by
using an international data source, with similar
procedures, methods, and questions for all countries.18
Results of other studies
Our results agree well with those of national studies of
other data sources of the same period as our study. For
example, studies from southern Europe found weak
associations between socioeconomic status and smok›
ing among women.19–22
The results of a previous international comparison
should be interpreted with caution both because the
educational classifications differed between countries
and because information on the comparability of the
smoking data and study populations was lacking.5 6
Nevertheless, comparatively large differences in smok›
ing were found in Great Britain and Norway and
smaller differences in Finland. In contrast to our study,
however, comparatively small differences were found
for men and women from Sweden.5
In another study, we calculated educational differ›
ences in current smoking for men and women aged
20›74 years, with data from the international Euroba›
rometer survey.23 The procedures, methods, and
questions from this survey are highly comparable
between countries but it has several disadvantages: a
higher non›response rate, a smaller number of respond›
ents per country, and a lack of data on most Nordic
countries. For the remaining countries, however, the
results corresponded well to those for the two age
groups combined in our study. The Eurobarometer data
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also showed a north›south pattern for women and com›
paratively small differences among men from Denmark
compared with Great Britain. A comparatively large dis›
crepancy was found only between the results for young
men from France, for whom the Eurobarometer data
showed much smaller differences than the national sur›
vey used in our current study.
The smoking epidemic
Several studies have shown that smoking spreads
through populations like an epidemic with four
stages.24 25 In stage 1, smoking is an exceptional
behaviour and mainly a habit of higher socioeconomic
groups. In stage 2, smoking becomes ever more com›
mon. Rates among men peak at 50%›80% and are equal
among socioeconomic groups or higher among higher
socioeconomic groups. In women these patterns usually
lag 10›20 years behind those of men. Smoking is first
adopted by women from higher socioeconomic groups.
In stage 3, prevalence rates among men decrease to
about 40% since many men stop smoking, especially
those who are better off. Women reach their peak rate
(35%›45%) during this stage, and at the end of this stage
their rates start to decline too. In stage 4, prevalence rates
keep declining slowly for both men and women, and
smoking becomes progressively more a habit of the
lower socioeconomic groups. During the smoking
epidemic there is a reversal from a positive to a negative
association between socioeconomic status and smoking.
On the basis of national prevalence rates for smok›
ing for men and women it has been hypothesised that
countries in southern Europe are in stage 2 (Portugal)
or at the beginning of stage 3 (Spain, Italy, France) of
the smoking epidemic, whereas northern European
countries are at the end of stage 3 or in stage 4.25 Our
findings on educational differences in smoking, with
“reverse” smoking gradients among women in
southern Europe and strong smoking gradients
among both men and women in northern Europe,
support this hypothesis.
Implications
Our study has several implications, both for the
explanation of socioeconomic inequalities in health and
for policies directed towards reducing socioeconomic
inequalities in health. Smoking is an important risk fac›
tor for disease, and it would therefore be expected that
socioeconomic inequalities in health are greater in
countries with greater inequalities in smoking, particu›
larly for diseases linked to smoking. An analysis of
differences in cause specific mortality by occupational
class for middle aged men partly confirms this.4 This
study found large differences in ischaemic heart disease
in Great Britain and the Nordic countries and small dif›
ferences in Switzerland, France, and more southern
European countries. This pattern is largely consistent
with the north›south pattern we found for differences in
smoking behaviour among men aged 45›74 years. We
found a significant positive association between differ›
ences in ischaemic heart disease and differences in cur›
rent (r = 0.65, P = 0.06) and ever smoking (r = 0.76,
P = 0.02). Large differences in lung cancer were
observed in northern European countries, particularly
Finland, and the southern European countries.4 An
exception was Portugal for which no differences were
observed. The findings from Portugal are in accordance
with our results for smoking, but overall there are no
strong associations between the differences in lung can›
cer and differences in current (r = 0.22, P = 0.57) and
ever smoking (r = 0.38, P = 0.31). A possible explanation
for the lack of a clear association is that our smoking
data do not give an accurate estimate of life time
exposure to smoking in the age groups.
Our study also has several implications for policy.
Firstly, socioeconomic inequalities in morbidity and
mortality related to smoking are likely to increase in the
future, and therefore a reduction of inequalities in health
will require powerful policies. Most studies of socioeco›
nomic inequalities in mortality deal with middle aged
men and, occasionally, women. Our results show that
social gradients in smoking are steeper in younger men
and women than in these older generations (tables 2 and
3), and it is likely that these steeper gradients of smoking
will translate into steeper gradients in morbidity and
mortality related to smoking in the future. This applies
to all countries in this study, but perhaps more to south›
ern European countries where the current small or even
reversed inequalities in mortality from ischaemic heart
disease may develop into patterns similar to those in
northern Europe.4
How can socioeconomic inequalities in smoking be
reduced? It is likely that they have arisen partly as a result
of health education efforts: due to the largely cognitive
nature of conventional health education and its depend›
ence on voluntary behavioural change, it will have had a
larger effect on higher educated people. A major prior›
ity for public health should be the development of
antismoking policies and interventions, which are effec›
tive in low socioeconomic groups, perhaps using pricing
policies and community based approaches.
We thank the national statistical offices of all participating coun›
tries for providing unpublished data from their national surveys,
the National Public Health Institute of Finland for data from the
What is already known on this topic
Smoking is more prevalent in the lower than
higher socioeconomic groups, particularly in
northern European countries such as the United
Kingdom
Previous studies have suggested that there may be
international variations in these differences in
smoking, but these were comparatively smallscale
studies without much attention to comparability of
data between countries
What this study adds
In most countries smoking is more prevalent
among the lower educated, although there are
important international variations
A north›south pattern, with strong gradients in
northern European countries and weaker or
reversed gradients in southern European
countries, was found for women and to a lesser
extent for men in the 45›74 year age group but
not for younger men
Smoking differences were larger among younger
than older people in most countries
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health behaviour monitoring survey among the Finnish adult
population, 1990›1. Material from the general household
survey, 1990›1, is Crown copyright; it has been made available
by the Office for National Statistics through the data archive and
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nomic inequalities in morbidity and mortality, which is
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results were discussed at three workshops.
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Evaluating “payback” on biomedical research from papers
cited in clinical guidelines: applied bibliometric study
Jonathan Grant, Robert Cottrell, Françoise Cluzeau, Gail Fawcett
Abstract
Objectives To develop a methodology for evaluating
the impact of research on health care, and to
characterise the papers cited on clinical guidelines.
Design The bibliographic details of the papers cited
in 15 clinical guidelines, developed in and for the
United Kingdom, were collated and analysed with
applied bibliometric techniques.
Results The median age of papers cited in clinical
guidelines was eight years; most papers were
published by authors living in either the United States
(36%) or the United Kingdom (25%)—this is two and a
half times more than expected as about 10% of all
biomedical outputs are published in the United
Kingdom; and clinical guidelines do not cite basic
research papers.
Conclusion Analysis of the evidence base of clinical
guidelines may be one way of tracking the flow of
knowledge from the laboratory to the clinic.
Moreover, such analysis provides a useful, clinically
relevant method for evaluating research outcomes
and different strategies in research and development.
Introduction
The United Kingdom spends over £1600 million a
year on non›commercial biomedical and health
services research.1 This research is funded either from
the public purse, such as the NHS and the Medical
Research Council, or medical research charities, such
as the Wellcome Trust. The tacit understanding is that
the biomedical research these bodies support will lead
to an eventual improvement in health. The system is
highly complex, however, and medical agencies
support a wide spectrum of activity from basic
biomedical research through to research in health
services and assessments of technology. Notwithstand›
ing this complexity, there is a need to understand how
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